Breast cancer screening is vital in reducing mortality rates associated with the disease. However, traditional mammography, despite its effectiveness, often results in false positives, leading to unnecessary stress and procedures for patients. A recent…
Continue Reading
Background: Young women often face substantial psychological challenges in the initial years following cancer diagnosis, leading to a comparatively lower quality of life than older survivors. While mobile apps have emerged as potential interventions,…
Continue Reading
By Shania Kennedy
May 31, 2024 – A magnetic resonance imaging (MRI)-based machine learning approach developed by researchers at UT Southwestern Medical Center could improve the detection of breast cancer metastasis and reduce the need for…
Continue Reading
What You Should Know:
– Color Health, a leader in comprehensive cancer care, announced today that it is partnering with SkinIO and Bexa to integrate their innovative solutions for skin and breast cancer screening into…
Continue Reading
What You Should Know:
– A collaborative effort between COTA, PreciseDx, and Baptist Health South Florida seeks to revolutionize breast cancer recurrence risk assessment with the PreciseBreast™ (PDxBr) test. This AI-powered tool holds promise for…
Continue Reading
Table of Contents
Introduction
Study Overview
Implications for Cardiovascular Risk Stratification
Integration into Clinical Practice
Further Research and AI Applications
FAQs
Introduction
Routine mammographic screenings are generally utilized for the detection of breast cancer. However, emerging research, including the study presented by…
Table of Contents
Introduction
Leadership Transition at ScreenPoint Medical
Vision and Expectations Under New Leadership
Impact on Breast Cancer Detection Technology
Reactions and Endorsements
FAQs
Introduction
ScreenPoint Medical, a leading provider of artificial intelligence (AI) solutions for breast cancer detection, has recently…
By Shania Kennedy
May 06, 2024 – Researchers from the University of Texas (UT) Southwestern Medical Center have developed a computational tool to predict breast cancer immunotherapy response by analyzing how cancer and immune cells interact.
The…
What You Should Know: – G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, and Pepper Bio, the world’s first transomics drug discovery and development company, announced a global licensing agreement (excluding the Asia-Pacific…
Continue Reading
What You Should Know:
– G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, and Pepper Bio, the world’s first transomics drug discovery and development company, announced a global licensing agreement (excluding the Asia-Pacific region)…
Continue Reading
